Menjugate: A Meningococcal C meningitis vaccine
Menjugate vaccine is used to prevent the Meningococcal Meningitis disease. It is vaccine by GSK pharma. It is Killed Meningococcal vaccine.
Menjugate Menongococcal Meningitis Vaccine is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup C. Menjugate Menongococcal Meningitis Vaccine is approved for use in persons aged 2 months. Menjugate Menongococcal Meningitis Vaccine does not prevent N. meningitidis serogroup B infections.
This vaccine is available in 0.5 ml dosages.
How is Menjugate Meningococcal Meningitis vaccine available?
Menjugate Menongococcal Meningitis Vaccine is available as injection liquid form. It is available as pre filled syringe. The pre filled syringe should be kept in out carton to keep it protected from the light. The fluid in syringe looks slightly cloudy and opalascent colorless.
How is Menjugate Meningococcal Meningitis vaccine stored?
Menjugate Menongococcal Meningitis Vaccine is stored at 2-8 degree Celsius. The temperature range should be maintained with the help of cold chain. The temperature range should be maintained at all levels of transport and storage. The vaccine should not be frozen. If the vaccine is frozen accidentally it should be discarded and not used for the injection. It should be stored in our carton that comes with the syringe to protect it from light. While discarding unused or used product all the local protocols for biomedical waste management should be followed.
How is Menjugate Meningococcal Meningitis vaccine given?
Menjugate Menongococcal Meningitis Vaccine is given on anterolateral aspect of thigh in infants and young children. This vaccine can be given in deltoid in choulder in adolescents. All the safe injection precautions should be followed while giving injection. The disposables should be discarded as per biomedical waste management protocols. The vaccine that has passed expiry should be discarded as per biomedical waste management protocol rules.
For those who have bleeding disorder this vaccine can be administered subcutaneously and firm pressure is given after the vaccination. The vaccination should be preferably planned after getting the dose of clotting factor in haemophilliacs.
At what age Menjugate Meningococcal Meningitis vaccine is given?
In children initiating vaccination at 2 months of age. 2 doses 2 months apart can be given for age below 1 year.
For those above age 1 year single dose is recommended.
A single booster dose of MENVEO may be administered to individuals aged above 1 year.
How does Menjugate Meningococcal Meningitis vaccine works?
Menjugate Menongococcal Meningitis Vaccine is a killed vaccine. It is used to prevent the infection and inflammation caused by Neisseria meningitidis serogroup C. This Neisseria meningitidis is also called as meningococcus because it infects the meninges the thin covering of the brain and causes disease meningitis which is life threatening in many cases even after treatment. This vaccination is active form of immunization and when it is injected in adequate doses to someone the immunity of the host recognizes the antigens in this vaccine as foreign antigens and form immune response against these antigens. When given as per schedule in adequate doses as suggested body also develops long term immunity in the process. When the real infection occurs the body fights the infection more vigorously and the disease is prevented. Thus this is active form of immunization.
Safety with other vaccine:
Menjugate Menongococcal Meningitis Vaccine is safe with most other medicine and no drug interactions were noted. The other vaccine or other drug should not be mixed in same syringe as this vaccine.
Like other inactivated vaccines Menjugate Menongococcal Meningitis Vaccine is considered as safe in pregnant and lactating woman, but the risk benefit ratio should be evaluated by the caregiver.
Concomitant administration of typhoid, tetanus and yellow fever vaccine is safe with Menjugate Menongococcal Meningitis Vaccine.
This vaccine is also safe when given with diphtheria, pertussis, HiB and pneumococcal vaccines.
What are side effects of Menjugate Meningococcal Meningitis vaccine?
This Menongococcal Meningitis Vaccine causes side effect that are generally milder and can be managed at home and does not need hospital admission:
- Fever is common side effect after the vaccination. It usually subsides in 1-3 days and can be managed very easily at home with medicine like paracetamol and sponging.
- Swelling and pain occurs at injection site may last for 1-3 days can be managed with paracetamol and local cold compression.
- Diarhea and loss of appetite can occur after vaccination and can be managed by oral rehydrating solution.
- Nausea and vomiting may occur after the vaccination and it can be managed by oral syp ondansetron and oral rehydrating solution.
- Muscular pain and joint pain.
- Headache and fatigue.
- Anaphylaxis and allergy is extremely rare side effect of the vaccine. Like other vaccines the vaccine should be administered at center where necessary personnel and drugs and equipments are available to manage if any reaction occurs.